As of 2024-10-13, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is (177.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.65 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is -516.6%.
The range of the Relative Valuation is (178.20) - (169.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 46.1x | 30.6x |
| Forward P/E multiples | 24.5x - 26.5x | 24.8x |
| Fair Price | (178.20) - (169.86) | (177.68) |
| Upside | -517.8% - -498.3% | -516.6% |
| Date | P/E |
| 2024-10-11 | -6.65 |
| 2024-10-10 | -6.52 |
| 2024-10-09 | -6.37 |
| 2024-10-08 | -6.31 |
| 2024-10-07 | -6.33 |
| 2024-10-04 | -6.44 |
| 2024-10-03 | -6.32 |
| 2024-10-02 | -6.51 |
| 2024-10-01 | -6.62 |
| 2024-09-30 | -6.93 |
| 2024-09-27 | -7.11 |
| 2024-09-26 | -7.49 |
| 2024-09-25 | -7.64 |
| 2024-09-24 | -7.26 |
| 2024-09-23 | -7.13 |
| 2024-09-20 | -7.26 |
| 2024-09-19 | -7.39 |
| 2024-09-18 | -7.10 |
| 2024-09-17 | -7.12 |
| 2024-09-16 | -7.08 |
| 2024-09-13 | -7.28 |
| 2024-09-12 | -7.00 |
| 2024-09-11 | -6.91 |
| 2024-09-10 | -6.94 |
| 2024-09-09 | -6.85 |
| 2024-09-06 | -6.75 |
| 2024-09-05 | -6.87 |
| 2024-09-04 | -6.98 |
| 2024-09-03 | -6.97 |
| 2024-08-30 | -7.16 |
| 2024-08-29 | -7.15 |
| 2024-08-28 | -7.07 |
| 2024-08-27 | -7.34 |
| 2024-08-26 | -7.26 |
| 2024-08-23 | -7.21 |
| 2024-08-22 | -7.12 |
| 2024-08-21 | -7.34 |
| 2024-08-20 | -6.99 |
| 2024-08-19 | -7.09 |
| 2024-08-16 | -7.02 |
| 2024-08-15 | -7.00 |
| 2024-08-14 | -6.97 |
| 2024-08-13 | -7.03 |
| 2024-08-12 | -6.97 |
| 2024-08-09 | -6.81 |
| 2024-08-08 | -6.83 |
| 2024-08-07 | -6.64 |
| 2024-08-06 | -6.64 |
| 2024-08-05 | -6.64 |
| 2024-08-02 | -6.85 |